Quality of Life, Functioning, and Depressive Symptom Severity in Older Adults With Major Depressive Disorder Treated With Citalopram in the STAR*D Study.
PubWeight™: 0.75‹?›
Published in J Clin Psychiatry on July 01, 2017
Authors
Alexander J Steiner1, Jennifer Recacho1, Brigitte Vanle1, Jonathan Dang1, Stephanie M Wright2, Justin S Miller1, Kaitlyn Kauzor1, Mark Reid1, Luma E Bashmi1, James Mirocha3, Itai Danovitch1,4, Waguih William IsHak5,1,4
Author Affiliations
1: Department of Psychiatry and Behavioral Neurosciences, Cedars-Sinai Medical Center, Los Angeles, California, USA.
2: Department of Pediatrics, Children's Hospital, Los Angeles, California, USA.
3: Biostatistics Core, Research Institute and Clinical & Translational Science Institute (CTSI), Cedars-Sinai Medical Center, Los Angeles, California, USA.
4: Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, USA.
5: Department of Psychiatry and Behavioral Neurosciences, Cedars-Sinai Medical Center, 8730 Alden Dr, Thalians E-132, Los Angeles, CA 90048. waguih.ishak@cshs.org.